Skip to Main Content
CWRU Links

August 20, 2014

AACI Members Choose Stan Gerson for New Leadership

August 20, 2014

Dr. Stan GersonThe Association of American Cancer Institutes (AACI) announces the election of Stanton L. Gerson, MD, as vice-president/president-elect effective in October 2014.

Dr. Gerson is the Asa and Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology, director of the National Cancer Institute (NCI)-Designated Case Comprehensive Cancer Center, in Cleveland, OH, founding director of the National Center for Regenerative Medicine, and Distinguished University Professor at Case Western Reserve University. He is also director of University Hospitals Seidman Cancer Center in Cleveland and a member of the NCI Board of Scientific Advisors.

Also elected to AACI's Board of Directors were Patrick J. Loehrer, Sr., MD, director of the Indiana University Melvin and Bren Simon Cancer Center, in Indianapolis, IN, and Thomas A. Sellers, PhD, MPH, director and executive vice president of the Moffitt Cancer Center and Research Institute, in Tampa, FL.

In a statement submitted to AACI members, Dr. Gerson said that in his new AACI leadership role, he will prioritize three critical aspects of the nation's cancer centers program by: 1) encouraging the centers to work more closely together to lower health care costs and improve outcomes through nationally coordinated research and translation; 2) expanding the use of cancer patient data to further health improvements and research discoveries; and 3) making optimal use of the cancer center director and administrative leader network, including partnering with funding agencies, to set the policy agenda for cancer research, dissemination of discoveries, and cancer health care.

Dr. Gerson has been an active member of AACI for the past 12 years, including service on the board of directors (2007-2009). He is currently a member of the AACI Molecular Diagnostics Initiative, which is tasked with coordinating optimal approaches to cancer genomics across cancer centers.

"I look forward to Stan's expanded leadership position with AACI," said AACI Executive Director Barbara Duffy Stewart. "As both a researcher and administrator, Stan possesses the expertise and range of skills that will propel AACI's continued support of its members' collaborative efforts toward a cancer-free world."

Dr. Gerson graduated from Harvard College [magna cum laude] and Harvard Medical School [cum laude]. In 1983, after completing his residency and hematology and oncology fellowship training at the Hospital of the University of Pennsylvania, he joined the faculty at Case Western Reserve University. He has been active in the stem cell, hematologic malignancies, and developmental therapeutics programs.

Drs. Gerson, Loehrer, and Seller' terms will commence on October 27 during the AACI/CCAF annual meeting, which will be held in Chicago, October 26-28.

The AACI comprises 93 premier academic and freestanding cancer research centers in the United States. AACI is dedicated to reducing the burden of cancer by enhancing the impact of the nation's leading academic cancer centers. A key element of AACI's mission is to assist the centers in keeping pace with the changing landscape in science, technology and health care. AACI does this by gathering and sharing best practices among cancer centers, providing a forum for our members to address common challenges and explore new opportunities, supporting initiatives that engage the membership in developing specific recommendations to the NCI, and educating policy makers about the important role cancer centers play in advancing cancer discovery.

Christine A. Somosi
Director of Marketing and Communications

About Case Comprehensive Cancer Center
Case Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center located at Case Western Reserve University. The center, which has been continuously funded since 1987, integrates the cancer research activities of the largest biomedical research and health care institutions in Ohio – Case Western Reserve, University Hospitals (UH) Case Medical Center and the Cleveland Clinic. NCI-designated cancer centers are characterized by scientific excellence and the capability to integrate a diversity of research approaches to focus on the problem of cancer. It is led by Stanton Gerson, MD, Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology, who is also the Director of the Seidman Cancer Center at UH Case Medical Center and Director of the National Center for Regenerative Medicine, Case Western Reserve University.